Skip to main content

Table 2 Immunoassay specifications

From: Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer’s disease: results from the DELCODE study

Protein

Assay CV (median, SD, min–max)

Single-/multiplex

Vendor

Assay method

Product no.

Dilution (x-fold)

FABP-3

3.4 ± 2.9

0.0–15.1

3-plex

Merck KGaA

Bead-based (Luminex Corp.)

HNS2MAG-95K

5

Neurogranin

2.6 ± 3.0

0.0–17.2

Ferritin

3.7 ± 4.5

0.0–19.8

C1q

2.2 ± 2.8

0.0–18.6

6-plex

HCMP2MAG-19K

4000

C3

1.6 ± 2.4

0.0–15.8

C4

1.6 ± 2.3

0.0–19.6

Factor B

2.0 ± 2.9

0.0–19.2

Factor H

1.7 ± 2.5

0.0–18.8

C3b

3.7 ± 4.3

0.0–19.8

sAXL

1.3 ± 1.8

0.0–16.8

Singleplex

R&D Systems, Inc.

Colorimetric

DY154

250

sTyro3

2.0 ± 2.5

0.0–16.5

Singleplex

DY850

6

YKL-40

1.2 ± 1.8

0.0–19.4

Singleplex

DY2599

200

IL-6

1.9 ± 1.7

0.0–10.0

Singleplex

Quanterix Corp.

Digital ELISA (SIMOA)

101622

5

Il-18

2.1 ± 2.0

0.0–10.0

Singleplex

102700

500

CXCL10

2.2 ± 2.2

0.0–11.3

3-plex

Meso Scale Diagnostics, LLC.

Electrochemi-luminescence

U-PLEX K15047K and K15046K

15

CCL2

1.7 ± 1.5

0.0–10.4

MIF

1.2 ± 1.6

0.0–18.2

CRP

1.8 ± 1.7

0.0–11.4

Singleplex

K15198D

1000

ApoE (total)

3.5 ± 3.7

0.0–17.3

Singleplex

F212I

4000

sTREM2

4.2 ± 4.3

0.0–18.8

Singleplex

Homebrew

5

  1. The table displays details on the single- and multiplex ELISA kits used. Methods for the homebrew sTREM2 ELISA have been described elsewhere [37]. Assay CV reports the median coefficient of variance with standard deviation, minimum, and maximum. The maximum accepted CV was 20%; samples exceeding this limit underwent repeated measurement (see the “Methods” section)